Mitsubishi Tanabe Pharma

  • About Us
    close
    About Us

    Message from
    the Management

    Facts about
    the Company

    • Philosophy, Vision and
      Corporate Behavior Charter
    • Materiality
    • Medium-Term
      Management Plan
    • Corporate Profile
    • Management
    • Organization Chart
    • Network
    • Group Companies
    • Brand Mark
    • Corporate History
    • Corporate Original Character
      "Tanamin"
    • Financial Information
    • Compliance
      • Code of Conduct
      • Policies
  • News
  • R&D
    close
    R&D

    Pipeline

    • R&D News
    • Maximizing Pipeline Value
    • Clinical Trial Information
  • Sustainability
    close
    Sustainability
    Message from the Chief Sustainability Officer

    Message from the Chief Sustainability Officer

    • Sustainability News
    • Mitsubishi Tanabe Pharma's Sustainability
    • Stakeholder Engagement
    • Materiality
    • Value Creation Model

    Sustainability Initiatives

    • Management
    • Environment
    • Society
    • Editorial Policies
    • External Evaluations
    • Data
    • Sustainability Report Archive
    • GRI Standard Comparative Table
    • Explanation of Terms
日本語
Contact Us
Mitsubishi Chemical Holdings Group
Search
menu
Search

Recent News

RSS

View more

Mitsubishi Tanabe Pharma Historical Museum

About Us

We contribute to
the healthier lives of
people around the world
through the creation of
pharmaceuticals.

View more

Message from the Management

Facts about the Company

Mitsubishi Tanabe Pharma in Numbers


Medium-Term Management Plan

R&D

Open up the future of
medical care

View more

  • Immuno-
    inflammation
  • Diabetes
    and kidney
  • Central
    nervous
    system
  • Vaccines
Pipeline
Clinical Trial Information

Sustainability

Achieving a healthy
and sustainable society
through medical care

View more

For the realization of a sustainable society where all the people can lead active lives

We contribute to extending the healthy life expectancy of people and achieving a sustainable society.

Sustainability Report Archive
Message from the Chief Sustainability Officer Mitsubishi Tanabe Pharma's Sustainability

Link

  • Yoshitomiyakuhin Corporation
  • Tanabe Research Laboratories U.S.A., Inc.
  • Mitsubishi Tanabe Pharma America, Inc.
  • Mitsubishi Tanabe Pharma Canada, Inc.
  • Mitsubishi Tanabe Pharma Development America, Inc.
  • MP Healthcare Venture Management, Inc.
  • Medicago Inc.
  • Mitsubishi Tanabe Pharma Europe Ltd.
  • Mitsubishi Tanabe Pharma GmbH
  • NeuroDerm Ltd.
  • Taiwan Tanabe Seiyaku Co., Ltd.
  • Mitsubishi Tanabe Pharma Korea Co., Ltd.
  • PT Mitsubishi Tanabe Pharma Indonesia
  • Mitsubishi Chemical Holdings
  • MITSUBISHI CHEMICAL
  • LSII
  • NIPPON SANSO HOLDINGS
About Us
  • Message from the Management
  • Philosophy, Vision and
    Corporate Behavior Charter
  • Medium-Term Management Plan
  • Corporate Profile
  • Management
  • Organization Chart
  • Network
  • Group Companies
  • Brand Mark
  • Corporate History
  • Facts about the Company
  • Corporate Original Character "Tanamin"
  • Financial Information
  • Compliance
News
R&D
  • R&D News
  • Maximizing Pipeline Value
  • Pipeline
  • Clinical Trial Information
Sustainability
  • Sustainability News
  • Message from the Chief Sustainability Officer
  • Mitsubishi Tanabe Pharma's Sustainability
  • Stakeholder Engagement
  • Materiality
  • Value Creation Model
  • Management
  • Environment
  • Society
  • Editorial Policies
  • External Evaluations
  • Data
  • Sustainability Report Archive
  • GRI Standard Comparative Table
  • Explanation of Terms
About Us
News
R&D
Sustainability
  • Terms of Use
  • Privacy Policy
  • Site Map
Copyright © Mitsubishi Tanabe Pharma Corporation.
All Rights Reserved.
Page top